Since the survival of injured β-cells in T2D depends on the glycolytic HIF1α–PFKFB3 pathway13, targeting this pathway may differentially affect the fates of healthy and injured β-cells. The gene discussed is HIF1A; the disease is type 2 diabetes mellitus.